|
||||||||||||||||||||
Title: |
Liver Damage After Radiofrequency Ablation Combined with Transcatheter Therapy in Treating Rabbit VX2 Liver Tumors | |||||||||||||||||||
| Authors: | Xu-Hua Duan, M.D., Wen-Hui Wang, M.M., Xin-Wei Han, M.D., Jian-Zhuang Ren, M.D., Hao Li, M.M., Peng-Fei Chen, M.M., Shao-Jun Gong, M.M., and Dong-Lin Kuang, M.M. | |||||||||||||||||||
|
Objective: To evaluate the effect of transcatheter therapies combined with radiofrequency ablation (RFA) treatment on hepatocellular necrosis, apoptosis, and proliferation by using the rabbit VX2 tumor model.
Study Design: Ninety-six models were randomly divided into 4 groups: transcatheter arterial chemoembolization (TACE) group, radiofrequency ablation group (RFA) group, TACE+RFA group, and transcatheter arterial embolization (TAE)+RFA group. Results: The high expression of heat shock protein 70 (HSP70) was observed in the adjacent liver tissue in TACE and TACE+RFA. The highest increase of transaminase levels and serum HSP70 were detected in the TACE+RFA group. The TAE+RFA group had a low apoptotic rate and more hepatocyte proliferation as compared to the TACE and TACE+RFA groups, and it had the longest end-point survival among these groups. Conclusion: The TAE+RFA treatment had a better outcome than RFA, including better liver tumor control, less liver injury, and a longer survival. Compared to TACE and TACE+RFA procedures, TAE+RFA significantly decreased the liver injury, hepatocellular necrosis, apoptosis, and systemic proinflammatory cytokine release caused by anticancer drug application. |
||||||||||||||||||||
| Keywords: | HSP70 heat-shock proteins, radiofrequency ablation, TACE, TAE, therapeutic chemoembolization, transcatheter arterial chemoembolization, transcatheter arterial embolization | |||||||||||||||||||
| Acrobat Reader 7.0 is recommended to properly view and print the article.
Reader can be downloaded from  |
||||||||||||||||||||
